Myriad Genetics, Inc. (NASDAQ: MYGN) has entered into a definitive agreement to acquire Crescendo Bioscience, Inc., a global leader in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hot Corp. News Management Comments Mergers and Acquisitions Trading Halts

Credit Suisse Upgrades Myriad Genetics (MYGN) to NeutralFebruary 7, 2014 6:50 AM Ladenburg Thalmann Downgrades Myriad Genetics (MYGN) to NeutralFebruary 5, 2014 8:17 AM JMP Securities Upgrades Myriad Genetics (MYGN) to Market PerformFebruary 5, 2014 6:56 AM Myriad Genetics, Inc. (MYGN) Tops Q2 EPS by 20c; Boosts FY14 OutlookFebruary 4, 2014 4:07 PM Myriad Genetics, Inc. (MYGN) trading halted with news pendingFebruary 4, 2014 4:01 PM